Viewing Study NCT01484860

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-02-02 @ 3:14 AM
Study NCT ID: NCT01484860
Status: TERMINATED
Last Update Posted: 2019-02-15
First Post: 2011-11-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy
Sponsor: University Health Network, Toronto
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Pancreas View
None Metastatic Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AUY922 View
None Pancreas View
None Pancreatic cancer View
None Adenocarcinoma of the pancreas View
None Cancer of the pancreas View
None Metastatic View
None Advanced View
None Advanced disease View
None Prior systemic anticancer therapy View